Execution Models
Execute with efficacy and control; orchestrate industry partnerships and milestone-driven vehicles in dedicated sub-funds to ensure transparent governance, paced financing, and accelerated market entry.
Chain Master + Fund
Cedar Lifetech Ventures VCC orchestrates the value chain, anchor enterprise, and industrial fund into a single coordinated mechanism—co-investing alongside industry leaders, mobilising additional capital, and accelerating the regional expansion of high-quality healthcare companies across Asia.
In practice, we partner closely with anchor enterprises to acquire and compound equity assets that are rooted in China, deeply established across Asia, and serving global markets. This generates a gravitational effect: as we invest in and empower our portfolio companies, influential Asian pharmaceutical firms are drawn to Singapore to anchor and scale—forming a fund-and-industry cluster in which capital and operations reinforce one another through strategic investment and M&A.
The result is genuine new competitive advantage for Singapore—closely aligned with the long-term China–Singapore cooperation agenda and with Singapore's positioning as a hub for advanced manufacturing and medical technology. Operationally, the fund architecture allows us to access deeper pools of capital, expand portfolio scale and technological depth, and reinforce Singapore as the destination of choice for healthcare anchoring and expansion in Asia.
NewCo (Overseas Rights)
For pipelines best positioned for an ex-China growth narrative, we establish NewCos to hold the overseas rights of core assets, attracting international capital and assembling globally minded management teams. The model concentrates financing on a single pipeline or a tightly focused product set, optimises the capital narrative for international markets, and uses Singapore as the bridgehead for overseas IP build-out and commercialisation.
Operating independently while drawing on Singapore's local industrial resources, the NewCo benefits from resource integration, shared risk, aligned incentives, agile decision-making, brand-building, and faster market access—accelerating the international expansion of the wider industrial ecosystem and supply chain.
Execution proceeds in two clear, decisive phases:
-
Transaction phase (approximately 6 months). NewCo incorporation, business plan, investor list and roadshow, management team assembly, pipeline due diligence, and the execution of licensing agreements—concluding with company registration and the closing of investor capital. This phase moves faster than direct equity investment or complex BD transactions because diligence focuses on a clearly defined asset and structure.
-
Operating phase (2–3 years). Activity centres on financing and pipeline development—maximising capital leverage, with subsequent funding milestones adjusted dynamically in response to competitive and commercial conditions. In the early stages, a Hybrid NewCo model—pairing domestic and overseas teams in complementary roles—can accelerate execution and de-risk scale-up.
These NewCos are housed within ring-fenced sub-funds, with terms calibrated to milestone profile, currency choice, and liquidity needs—giving investors transparent, milestone-linked exposure while preserving strategy purity at the platform level.
